Compare ALKS & CBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALKS | CBC |
|---|---|---|
| Founded | 1987 | 1902 |
| Country | Ireland | United States |
| Employees | 2050 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.7B |
| IPO Year | 2012 | 2025 |
| Metric | ALKS | CBC |
|---|---|---|
| Price | $45.24 | $35.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 5 |
| Target Price | ★ $56.21 | $35.20 |
| AVG Volume (30 Days) | ★ 1.9M | 818.9K |
| Earning Date | 11-03-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 1.38% |
| EPS Growth | N/A | ★ 25.90 |
| EPS | N/A | ★ 0.94 |
| Revenue | ★ $1,475,899,000.00 | N/A |
| Revenue This Year | $23.57 | $8.19 |
| Revenue Next Year | $6.58 | $5.80 |
| P/E Ratio | ★ N/A | $36.89 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.00 | $22.50 |
| 52 Week High | $55.67 | $35.12 |
| Indicator | ALKS | CBC |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 68.14 |
| Support Level | $39.41 | $30.44 |
| Resistance Level | $45.20 | N/A |
| Average True Range (ATR) | 1.39 | 0.84 |
| MACD | 0.62 | 0.23 |
| Stochastic Oscillator | 96.63 | 84.84 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Central Bancompany Inc is a bank holding company that provides a broad range of retail, corporate, mortgage banking, wealth management, and trust products and services to individuals and businesses. Its operating segments include Consumer, Commercial, and Wealth Management. The company generates the majority of its revenue from the Commercial segment, which provides full-service relationship banking solutions to businesses, agencies, and community organizations, including commercial, small business, and government clients. The segment also offers business payment solutions such as treasury management services, merchant services, and commercial bank card products.